What would a population-level approach to dementia risk reduction look like, and how would it work?

被引:37
作者
Walsh, Sebastian [1 ,8 ]
Govia, Ishtar [2 ]
Peters, Ruth [3 ]
Richard, Edo [4 ,5 ]
Stephan, Blossom C. M. [6 ]
Wilson, Nikki-Anne [3 ,7 ]
Wallace, Lindsay [1 ]
Anstey, Kaarin J. [3 ]
Brayne, Carol [1 ]
机构
[1] Univ Cambridge, Cambridge Publ Hlth, Cambridge, England
[2] Univ West Indies, Caribbean Inst Hlth Res, Epidemiol Res Unit, Mona Campus, Kingston, Jamaica
[3] Univ New South Wales, UNSW Ageing Futures Inst, Sydney, NSW, Australia
[4] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neurol, Med Ctr, Nijmegen, Netherlands
[5] Univ Amsterdam, Dept Publ & Occupat Hlth, Amsterdam UMC, Amsterdam, Netherlands
[6] Univ Nottingham Innovat Pk, Inst Mental Hlth, Jubilee Campus, Nottingham, England
[7] Neurosci Res Australia, Randwick, NSW, Australia
[8] Univ Cambridge, Cambridge Publ Hlth, Cambridge CB21PZ, England
关键词
dementia; public health; risk reduction; COGNITIVE FUNCTION; INTERVENTION; DETERMINANTS; ADULTS;
D O I
10.1002/alz.12985
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dementia is a leading global public health challenge. Prevention approaches have traditionally focused on individual-level strategies. However, such approaches have limited potential, particularly for resource-constrained populations in which exposure to risk factors is greatest, and exposure to protective factors is lowest. A population-level approach to dementia risk reduction is therefore essential to meet the scale of the challenge and to tackle global inequalities in risk and incidence of disease. Such approaches can be highly cost effective. In this viewpoint article, we describe what such an approach should look like, barriers and facilitators to success, and how we should go about achieving it. We include 10 strategic goals to achieve population-level dementia risk reduction and protection enhancement, targeted at researchers, professionals, funders, science communicators, governments, businesses, and policy makers. If we are to significantly reduce the prevalence of dementia there must be increased emphasis on population-level approaches. HighlightsDementia risk reduction is a global public health priorityPopulation-level approaches change societal conditions to make them less conducive to dementia's modifiable risk factors, and increase exposure to protective factors.Urgent development of population-level approaches is required to reduce the prevalence of, and inequalities in, dementiaAction is required from researchers, governments and business, funders, public health professionals, and science communicators.
引用
收藏
页码:3203 / 3209
页数:7
相关论文
共 37 条
[1]   Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis [J].
Ackley, Sarah F. ;
Zimmerman, Scott C. ;
Brenowitz, Willa D. ;
Tchetgen, Eric J. Tchetgen ;
Gold, Audra L. ;
Manly, Jennifer J. ;
Mayeda, Elizabeth Rose ;
Filshtein, Teresa J. ;
Power, Melinda C. ;
Elahi, Fanny M. ;
Brickman, Adam M. ;
Glymour, M. Maria .
BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
[2]  
Adams J, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1001990, 10.1371/journal.pmed.1002045]
[3]   Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial [J].
Andrieu, Sandrine ;
Guyonnet, Sophie ;
Coley, Nicola ;
Cantet, Christelle ;
Bonnefoy, Marc ;
Bordes, Serge ;
Bories, Lawrence ;
Cufi, Marie-Noelle ;
Dantoine, Thierry ;
Dartigues, Jean-Francois ;
Desclaux, Francoise ;
Gabelle, Audrey ;
Gasnier, Yannick ;
Pesce, Alain ;
Sudres, Kristel ;
Touchon, Jacques ;
Robert, Philippe ;
Rouaud, Olivier ;
Legrand, Philippe ;
Payoux, Pierre ;
Caubere, Jean-Paul ;
Weiner, Michael ;
Carrie, Isabelle ;
Ousset, Pierre-Jean ;
Vellas, Bruno .
LANCET NEUROLOGY, 2017, 16 (05) :377-389
[4]  
[Anonymous], 2009, EVALUATION SMOKEFREE
[5]  
[Anonymous], 2017, Tackling NCDs: best buys and other recommended interventions for the prevention and control of noncommunicable deseases
[6]   Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease [J].
Bateman, Randall J. ;
Xiong, Chengjie ;
Benzinger, Tammie L. S. ;
Fagan, Anne M. ;
Goate, Alison ;
Fox, Nick C. ;
Marcus, Daniel S. ;
Cairns, Nigel J. ;
Xie, Xianyun ;
Blazey, Tyler M. ;
Holtzman, David M. ;
Santacruz, Anna ;
Buckles, Virginia ;
Oliver, Angela ;
Moulder, Krista ;
Aisen, Paul S. ;
Ghetti, Bernardino ;
Klunk, William E. ;
McDade, Eric ;
Martins, Ralph N. ;
Masters, Colin L. ;
Mayeux, Richard ;
Ringman, John M. ;
Rossor, Martin N. ;
Schofield, Peter R. ;
Sperling, Reisa A. ;
Salloway, Stephen ;
Morris, John C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :795-804
[7]   Changes in Brain Function Occur Years before the Onset of Cognitive Impairment [J].
Beason-Held, Lori L. ;
Goh, Joshua O. ;
An, Yang ;
Kraut, Michael A. ;
O'Brien, Richard J. ;
Ferrucci, Luigi ;
Resnick, Susan M. .
JOURNAL OF NEUROSCIENCE, 2013, 33 (46) :18008-18014
[8]   Donepezil for dementia due to Alzheimer's disease [J].
Birks, Jacqueline S. ;
Harvey, Richard J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (06)
[9]   Rivastigmine for Alzheimer's disease [J].
Birks, Jacqueline S. ;
Chong, Lee Yee ;
Evans, John Grimley .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09)
[10]   No new fast-food outlets allowed! Evaluating the effect of planning policy on the local food environment in the North East of England [J].
Brown, Heather ;
Xiang, Huasheng ;
Albani, Viviana ;
Goffe, Louis ;
Akhter, Nasima ;
Lake, Amelia ;
Sorrell, Stewart ;
Gibson, Emma ;
Wildman, John .
SOCIAL SCIENCE & MEDICINE, 2022, 306